abiraterone acetate
(Abiraterone acetate)Apotex Corp.
Usage: Abiraterone acetate, in combination with prednisone, is indicated for treating metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).